Responses
Case Reports: Novel treatment (new drug/interventions; established drug/procedure in new situation)
Durable remission with Bruton’s tyrosine kinase inhibitor therapy in a patient with leptomeningeal disease secondary to relapsed mantle cell lymphoma
Compose a Response to This Article
Other responses
No responses have been published for this article.